Navigation Links
How does Mycobacterium tuberculosis infect the lung?

Tuberculosis (TB) is the most common major infectious disease today. It is estimated that two billion people--or one-third of the world's population--are chronically infected without active symptoms. Nine million new cases of active disease are diagnosed annually, resulting in two million deaths. TB is predominantly a lung disease. It is caused by a microbe called Mycobacterium tuberculosis which infects lung cells, but it is still not clear how exactly this happens. Ludovic Tailleux, Olivier Neyrolles, and colleagues (from the Pasteur Institute, in collaboration with the Necker and Saint-Louis Hospitals, in Paris) have found that a molecule called DC-SIGN plays a crucial part.

The researchers wanted to examine whether lung cells from patients with TB were different from those of healthy people or those with different lung diseases, and what that tells us about the way the infection spreads in the lung. In particular, they looked at the surface of the lung cells, because this is the part directly involved in the first contact with the Mycobacterium. As they report now in the international open-access medical journal PLoS Medicine, they studied 74 individuals, 40 of whom had TB, 25 had other inflammatory lung diseases, and 9 had neither active TB nor lung inflammation and served as healthy "controls." The patients underwent a procedure called broncho-alveolar lavage that washes out some of the secretions and cells from the lower respiratory tract. The researchers then analyzed the cells in different ways. They concentrated on a type of cell called a macrophage (the natural target of Mycobacterium) and found that macrophages from patients with TB had much more the DC-SIGN protein on their surface than macrophages from patients with other diseases or from the control individuals.

They then took macrophages from a control individual (which had very low levels of DC-SIGN) and infected them with Mycobaterium under laboratory conditions. They found that s hortly after infection not only the infected cells but also some of their neighbours started to display DC-SIGN on their surface. They also found that having DC-SIGN on the surface made uninfected cells much more susceptible to infection.

These results suggest that DC-SIGN has an important function in amplifying TB infection in the lung. Interfering with DC-SIGN function might therefore be a new way to fight TB, a disease that is becoming increasingly resistant to existing therapies and for which new drugs are urgently needed.


'"/>

Source:Public Library of Science


Related biology news :

1. Scientists find missing enzyme for tuberculosis iron scavenging pathway
2. New vaccine protects more effectively against tuberculosis
3. Scientists discover gene that controls speed of tuberculosis development
4. Once-dreaded leprosy replaced by tuberculosis, say researchers
5. Gene increases risk of tuberculosis
6. Experimental TB drug effective against resistant and latent mycobacterium tuberculosis
7. New potential drug target in tuberculosis
8. Pitt phage hunter takes on tuberculosis
9. World-wide warning of highly drug-resistant tuberculosis
10. Faster, more accurate tuberculosis test developed
11. New research may overturn conventional wisdom on drug-resistant tuberculosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/11/2017)... Intoxalock, a leading ignition interlock provider, has ... patent-pending calibration device. With this new technology, Intoxalock is ... data logs and process repairs at service center locations, ... drunk driving through the application of cutting-edge technologies is ... also for the customer who can get back on ...
(Date:1/6/2017)... Calif. , Jan. 6, 2017  Privately-held ... safety studies in healthy volunteers of a novel ... to treat acute pancreatitis. Acute ... typically a mild disorder, but can be very ... failure and sepsis, where extended hospital stays, time ...
(Date:1/6/2017)... Calif. , Jan. 5, 2017  Delta ID ... its iris scanning technology for automotive at CESĀ® 2017. ... GNTX ) to demonstrate the use of iris ... identify and authenticate the driver in a car, and ... during the driving experience. Delta ID and ...
Breaking Biology News(10 mins):
(Date:1/21/2017)... Jan. 20, 2017 Interpace Diagnostics Group, ... that provides clinically useful molecular diagnostic tests and ... into a securities purchase agreement with three  institutional ... of common stock in a registered direct offering.  ... agreed to sell to the same investors warrants ...
(Date:1/20/2017)... , January 20, 2017 Stock-Callers.com ... conditions have influenced the most recent performances of select ... (NASDAQ: RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... TBPH ), and Sage Therapeutics Inc. (NASDAQ: ... by Grand View Research, global Biotech market size is expected to ...
(Date:1/19/2017)... Research Future has a half cooked research report on Global Liquid ... and expected to reach USD 450 Million by the end of ... ... assessed as a swiftly growing market and expected that the market ... There has been a tremendous growth in the prevalence of cancer ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, ... biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide ... email client designed to provide product vigilance departments with the flexibility and ease ...
Breaking Biology Technology: